AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 30 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $17,305,000,000 | +4.9% | 22,000,000 | 0.0% | 0.62% | +64.6% |
| Q3 2018 | $16,497,000,000 | +7.1% | 22,000,000 | 0.0% | 0.38% | +22.7% |
| Q2 2018 | $15,406,000,000 | -11.6% | 22,000,000 | 0.0% | 0.31% | -8.0% |
| Q1 2018 | $17,427,000,000 | -15.8% | 22,000,000 | -15.4% | 0.34% | -8.4% |
| Q4 2017 | $20,695,000,000 | +0.1% | 26,000,000 | 0.0% | 0.37% | +22.3% |
| Q3 2017 | $20,669,000,000 | -0.6% | 26,000,000 | 0.0% | 0.30% | -11.8% |
| Q2 2017 | $20,800,000,000 | +0.6% | 26,000,000 | 0.0% | 0.34% | -2.6% |
| Q1 2017 | $20,670,000,000 | -4.2% | 26,000,000 | -14.8% | 0.35% | -16.3% |
| Q4 2016 | $21,579,000,000 | +7.7% | 30,500,000 | 0.0% | 0.42% | +39.9% |
| Q3 2016 | $20,035,000,000 | +33.1% | 30,500,000 | +17.3% | 0.30% | -8.3% |
| Q2 2016 | $15,049,000,000 | +8.2% | 26,000,000 | 0.0% | 0.32% | +27.5% |
| Q1 2016 | $13,910,000,000 | -19.7% | 26,000,000 | 0.0% | 0.26% | -12.4% |
| Q4 2015 | $17,312,000,000 | +49.8% | 26,000,000 | +73.3% | 0.29% | +23.8% |
| Q3 2015 | $11,556,000,000 | – | 15,000,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 24,200,000 | $17,243,000 | 10.27% |
| Context Capital Management, LLC | 3,910,000 | $2,830,000 | 3.10% |
| Telemetry Investments, L.L.C. | 4,500,000 | $3,206,000 | 1.81% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 65,567,000 | $47,208,000 | 0.84% |
| UBS OCONNOR LLC | 30,500,000 | $21,579,000,000 | 0.42% |
| K2 PRINCIPAL FUND, L.P. | 6,000 | $4,350,000 | 0.41% |
| Tekla Capital Management LLC | 13,000,000 | $9,263,000 | 0.40% |
| Baker Brothers Advisors | 26,517,000 | $19,103,000 | 0.19% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $1,069,000 | 0.14% |
| Orbimed Advisors | 8,000,000 | $5,976,000 | 0.08% |